Dongwu Pharmaceutical Shandong Co., Ltd

Medicine from the East Shine Global

Wu people refine excellent quality

global excellent supplier

Quality medicine for our people

Superior company for our society

01 / 03

Dongwu Pharmaceutical (Shandong) Co., Ltd

Company Profile

The company was established in February 2023 and is located in Tai'an Zhongzhi Life and Health Industrial Park, High tech Zone, Tai'an City. Its registered capital is 20 million US dollars and it covers an area of 80 acres. The company is built according to Chinese GMP standards and meets EU and US FDA certification standards. It has built 10 production workshops, analysis centers, comprehensive buildings, and related supporting units, with a total construction area of 69000 square meters. The company focuses on the research and development, production, and sales of high-end formulations such as long-acting formulations, sustained-release formulations, and targeted nano formulations, with research and development centers in Beijing and Guangzhou. At present, we have participated in the research and development of more than 20 listed products and more than 10 clinical products, involving full dosage forms of drugs such as cardiovascular and cerebrovascular nervous suppression, immune suppression, and tumor targeting.

Detail

R&D Center

The company has achieved industry-leading drug
research and development capabilities through cooperation
with professional higher education institutions and research
institutions both domestically and internationally

management system

Dongwu has always adhered to the ICH standard, passed the ISO9001 international quality management system certification, and introduced advanced database management systems to ensure the authenticity, security, and compliance of research and development data. It has reached advanced industry levels in project management systems, knowledge management systems, quality management systems, and data management systems.